In patient breast cancer tissue, we found NHE1 to be most highly expressed in well-perfused, peripheral tumor regions, while NBCn1 expression did not exhibit a detectable spatial gradient [15]. This evidence concerns the gene SLC9A1 and breast carcinoma.